Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2012; 18(31): 4199-4206
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4199
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4199
Group | n | ALP (U/L) |
Normal | 10 | 73.91 ± 5.97 |
CCl4-induced hepatic fibrosis | 10 | 550.69 ± 43.80e |
OM-RGD liposomes | 10 | 272.51 ± 19.55ac |
OM liposomes | 10 | 344.47 ± 27.52c |
RGD liposomes | 10 | 562.78 ± 40.22 |
Collagen area (%) | ||
CCl4-induced hepatic fibrosis | 5 | 7.70 ± 0.60 |
RGD liposomes | 5 | 8.32 ± 0.42 |
OM liposomes | 5 | 2.36 ± 0.09c |
OM-RGD liposomes | 5 | 0.26 ± 0.09e |
-
Citation: Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP, Wu BY. Oxymatrine liposome attenuates hepatic fibrosis
via targeting hepatic stellate cells. World J Gastroenterol 2012; 18(31): 4199-4206 - URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4199